Tao Ding

403 total citations
20 papers, 244 citations indexed

About

Tao Ding is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Tao Ding has authored 20 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Immunology and 3 papers in Surgery. Recurrent topics in Tao Ding's work include interferon and immune responses (2 papers), Cancer Mechanisms and Therapy (2 papers) and Cancer Research and Treatments (2 papers). Tao Ding is often cited by papers focused on interferon and immune responses (2 papers), Cancer Mechanisms and Therapy (2 papers) and Cancer Research and Treatments (2 papers). Tao Ding collaborates with scholars based in China, Hong Kong and United Kingdom. Tao Ding's co-authors include Ana Baião, Bruno Sarmento, Catarina Pacheco, Wenguo Cui, Li Ling, Ming Yang, Xin Gao, Zhe Lin, Sisi Huang and Lei Luo and has published in prestigious journals such as Cancer Research, Advanced Drug Delivery Reviews and Annals of Oncology.

In The Last Decade

Tao Ding

17 papers receiving 241 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tao Ding China 7 74 51 48 35 33 20 244
Nazima Haider Saudi Arabia 10 96 1.3× 72 1.4× 66 1.4× 16 0.5× 39 1.2× 46 328
Samar Saeed Khan Saudi Arabia 11 88 1.2× 27 0.5× 33 0.7× 22 0.6× 26 0.8× 33 282
Celia N. Sánchez‐Domínguez Mexico 13 115 1.6× 51 1.0× 56 1.2× 90 2.6× 32 1.0× 38 444
Fangfang Nan China 10 103 1.4× 41 0.8× 41 0.9× 59 1.7× 66 2.0× 14 435
Mi Ran Kim South Korea 9 106 1.4× 54 1.1× 82 1.7× 31 0.9× 37 1.1× 26 399
Yujing Huang China 4 69 0.9× 76 1.5× 45 0.9× 26 0.7× 18 0.5× 7 267
Huihao Xu China 7 105 1.4× 46 0.9× 83 1.7× 35 1.0× 36 1.1× 15 293
Islam A. Hassanin Egypt 6 130 1.8× 63 1.2× 113 2.4× 21 0.6× 50 1.5× 9 325

Countries citing papers authored by Tao Ding

Since Specialization
Citations

This map shows the geographic impact of Tao Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Ding more than expected).

Fields of papers citing papers by Tao Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tao Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Ding. The network helps show where Tao Ding may publish in the future.

Co-authorship network of co-authors of Tao Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Tao Ding. A scholar is included among the top collaborators of Tao Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tao Ding. Tao Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Bo, Weiyang Liu, Wan‐Hui Wang, et al.. (2025). CRISPR/Cas9-based discovery of ccRCC therapeutic opportunities through molecular mechanism and immune microenvironment analysis. Frontiers in Immunology. 16. 1619361–1619361.
2.
Ding, Tao, Lina He, Lei Xu, et al.. (2025). Integrated analysis of single-cell and bulk transcriptomes uncovers clinically relevant molecular subtypes in human prostate cancer. Chinese Journal of Cancer Research. 37(1). 90–114. 3 indexed citations
3.
Fung, Sin‐Yee, Tao Ding, Yuan Zhou, et al.. (2025). Centrosome protein TAX1BP2 mediates STING-dependent immune response and potentiates anti-PD-1 efficacy in hepatocellular carcinoma. Molecular Therapy. 33(6). 2913–2930.
4.
Wang, Hui, Li Yu, Pengcheng Zhou, et al.. (2024). Exosomal miR-205–5p contributes to the immune liver injury induced by trichloroethylene: Pivotal role of RORα mediating M1 Kupffer cell polarization. Ecotoxicology and Environmental Safety. 285. 117050–117050. 3 indexed citations
5.
Zhou, Yang, et al.. (2024). Precise In Situ Delivery of a Photo-Enhanceable Inflammasome-Activating Nanovaccine Activates Anticancer Immunity. Cancer Research. 84(22). 3834–3847. 4 indexed citations
6.
7.
Wu, Yi‐Long, Pan Liu, Tao Ding, et al.. (2023). 329MO HLX208, a novel BRAF V600E inhibitor, in adult patients with Langerhans cell histiocytosis and/or Erdheim-Chester disease harbouring BRAF V600E mutation. Annals of Oncology. 34. S1599–S1599. 1 indexed citations
8.
Lin, Datao, Jinni Hong, Jerome H. L. Hui, et al.. (2023). Core gut microbes Cloacibacterium and Aeromonas associated with different gastropod species could be persistently transmitted across multiple generations. Microbiome. 11(1). 267–267. 12 indexed citations
9.
Liu, Hui, Wai Ho Yeung, Li Pang, et al.. (2023). Arachidonic acid activates NLRP3 inflammasome in MDSCs via FATP2 to promote post-transplant tumour recurrence in steatotic liver grafts. JHEP Reports. 5(12). 100895–100895. 7 indexed citations
10.
Pacheco, Catarina, Ana Baião, Tao Ding, Wenguo Cui, & Bruno Sarmento. (2023). Recent advances in long-acting drug delivery systems for anticancer drug. Advanced Drug Delivery Reviews. 194. 114724–114724. 116 indexed citations
11.
12.
Pang, Li, Oscar W.H. Yeung, TP Ng, et al.. (2022). Postoperative Plasmacytoid Dendritic Cells Secrete IFNα to Promote Recruitment of Myeloid-Derived Suppressor Cells and Drive Hepatocellular Carcinoma Recurrence. Cancer Research. 82(22). 4206–4218. 30 indexed citations
13.
Wang, Yan, et al.. (2022). scBPGRN: Integrating single-cell multi-omics data to construct gene regulatory networks based on BP neural network. Computers in Biology and Medicine. 151(Pt A). 106249–106249. 3 indexed citations
14.
Zhang, Jingxiang, Yiping Wu, Jing Liu, et al.. (2022). Differential Oral Microbial Input Determines Two Microbiota Pneumo‐Types Associated with Health Status (Adv. Sci. 32/2022). Advanced Science. 9(32). 4 indexed citations
15.
16.
Wang, Yan, et al.. (2022). A network-based matrix factorization framework for ceRNA co-modules recognition of cancer genomic data. Briefings in Bioinformatics. 23(5). 10 indexed citations
17.
Ding, Tao, et al.. (2021). Comparison of etomidate and propofol-mediated anesthesia induction followed by intubation and sevoflurane maintenance during ERCP in obese patients.. American Journal of Translational Research. 13(8). 9853–9859. 6 indexed citations
18.
19.
Pan, Zheng‐Hong, et al.. (2015). A new picrotoxane sesquiterpene from the berries ofBaccaurea ramiflorawith antifungal activity againstColletotrichum gloeosporioides. Natural Product Research. 29(14). 1323–1327. 15 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nazima Haider Breakdown of academic impact, for papers by Samar Saeed Khan Breakdown of academic impact, for papers by Celia N. Sánchez‐Domínguez Breakdown of academic impact, for papers by Fangfang Nan Breakdown of academic impact, for papers by Mi Ran Kim Breakdown of academic impact, for papers by Yujing Huang Breakdown of academic impact, for papers by Huihao Xu Breakdown of academic impact, for papers by Islam A. Hassanin
Rankless by CCL
2026